Last updated: August 11, 2025
Introduction
Japan Patent JP2011157389, filed on July 12, 2011, and published on December 21, 2012, pertains to innovations in the pharmaceutical domain. Specifically, it relates to therapeutic agents, compositions, or methods involving novel compounds or formulations with potential applications in treating certain medical conditions. This analysis provides an in-depth examination of its claims, scope, and the broader patent landscape within the pharmaceutical sector, emphasizing current trends and strategic implications for stakeholders.
Scope of JP2011157389
The scope of JP2011157389 is primarily defined by the claims and description outlined in the patent document. It aims to cover:
- Novel Chemical Entities: The patent claims explore specific chemical compounds, likely derivatives or analogs of known pharmacophores, designed for therapeutic efficacy.
- Pharmacological Use: The claims extend to their use in specific treatment methods, focusing on diseases or conditions targeted by these compounds.
- Pharmaceutical Compositions: The scope encompasses formulations combining the compounds with carriers or additional agents, optimizing delivery and efficacy.
- Method of Production: Certain claims may include processes for synthesizing these compounds or compositions, emphasizing manufacturing relevance.
The patent claims span from broad to specific, aiming to secure comprehensive protection over both the chemical entities and their practical applications.
Claims Analysis
The claims serve as the legal basis for the patent's scope. Although the exact language from JP2011157389 is needed for precise delineation, typical claim structures in such patents include:
Independent Claims
-
Chemical Compound Claims: These specify the structure, substituents, and stereochemistry, often with Markush structures to cover a range of derivatives. For example, the claims may describe compounds with a core heterocyclic scaffold, substituted at specific positions.
-
Use Claims: Cover methods of using the compounds to treat particular diseases, such as neurodegenerative disorders, cancers, or inflammatory diseases. These claims typically specify dosage, administration route, and treatment regimen.
-
Composition Claims: Encompass pharmaceutical formulations containing the compounds alongside pharmaceutically acceptable carriers or adjuvants.
-
Process Claims: Include synthetic methods, potentially highlighting novel synthetic routes or intermediates that improve yield, purity, or scalability.
Dependent Claims
Dependent claims refine the independent claims by narrowing the scope to specific embodiments—such as particular substituents, salt forms, or formulations—thus providing fallback positions and enhancing enforceability.
Claim Strategy
The claim drafting appears to focus both on broad chemical classes and specific compounds, balancing robust protection with avoidance of prior art contention. The inclusion of method and composition claims broadens the patent’s commercial utility.
Patent Landscape Analysis
1. Global Patent Trends
In the field represented by JP2011157389, the global patent landscape indicates a significant interest in:
- Novel Psychotropic and Neuroprotective Agents
- Targeted Oncology Drugs
- Anti-inflammatory and Immunomodulatory Agents
Major jurisdictions such as the United States, Europe, and China host related patents, often featuring overlapping classes covering similar chemical scaffolds or therapeutic indications. The landscape is highly competitive, with key players filing constantly to secure strategic rights.
2. Patent Families and Priority
Japan's patent system often aligns with global filings, citing priority from initial applications in other jurisdictions, such as PCT applications or filings in the US and Europe. A review of patent family data suggests that the applicants have sought patent protection in:
- USA (US Patents)
- European Patent Office (EPO) Filings
- China (CN Patents)
- Korea (KR Patents)
Aligning filings across jurisdictions enhances the patent’s market position and reduces infringement risks.
3. Prior Art and Cited Art
The patent document likely references prior art through citations, including:
- Well-known chemical classes such as heterocyclic compounds or kinase inhibitors.
- Previously disclosed methods of synthesis or therapeutic uses.
- Related patents covering similar scaffolds or mechanisms-of-action.
Analyzing these citations reveals the inventive leap may lie in specific modifications or combinations that improve efficacy, reduce side effects, or simplify synthesis.
4. Freedom-to-Operate and Infringement Risks
This patent’s broad claims raise the question of overlapping rights with competing patents—common in the pharmaceutical field. Companies must:
- Conduct freedom-to-operate analyses focusing on the chemical scaffold and therapeutic claims.
- Monitor competitor portfolios to avoid infringement, especially given the dense patent landscape in relevant therapeutic areas.
Strategic and Commercial Implications
The patent's scope suggests its utility in protecting a pipeline of compounds with potential high-value therapeutic applications. The broad claims around chemical structure and uses afford flexibility in developing various formulations and derivatives, supporting downstream innovation.
However, maintaining strong patent defenses depends on continuous monitoring of prior art and competitors’ filings. The patent's validity period, usually 20 years from the filing date, underscores the importance of early filing and strategic claim drafting, especially in rapidly evolving fields like pharmaceuticals.
Key Takeaways
-
Comprehensive Claim Strategy: JP2011157389 employs broad and narrow claims that secure protection over the core chemical compounds, their uses, and formulations, providing a versatile platform for future development.
-
Robust Patent Landscape Position: It exists within a competitive, rapidly advancing patent space characterized by overlapping rights and diverse filings, requiring vigilant IP management for freedom to operate.
-
Innovation Focus: The patent likely leverages slight chemical modifications to existing classes, aiming to enhance therapeutic profiles or manufacturing processes.
-
Global Coverage: By aligning claims with international filings, the patent holder maximizes market reach and strengthens enforcement capabilities.
-
Continual Monitoring Needed: Given the dynamic nature of pharmaceutical patenting, ongoing landscape analysis is essential to maintain competitive advantage and avoid infringement.
FAQs
Q1: What is the primary focus of JP2011157389's claims?
A: The patent primarily claims novel chemical compounds, their therapeutic uses, pharmaceutical compositions, and methods of synthesis, aligned with specific medical indications.
Q2: How broad are the claims in this patent?
A: The claims appear to balance breadth—covering entire classes of compounds and their uses—with specificity through dependent claims on particular derivatives and formulations.
Q3: In what ways does this patent landscape impact drug development?
A: It defines protected chemical classes and therapeutic methods, guiding R&D directions while highlighting potential infringement risks and licensing opportunities.
Q4: Does JP2011157389 cover manufacturing processes?
A: Yes, certain claims likely include synthetic methods and intermediates, crucial for process innovation and patenting strategies.
Q5: What is the significance of the patent’s international filings?
A: These extend the patent right beyond Japan, offering broader market protection and reinforcing the patent holder’s global strategic position.
References
[1] Japan Patent Application JP2011157389. "Chemical compounds and therapeutic agents." Filed: 2011-07-12; Published: 2012-12-21.
[2] WIPO PatentScope. Global patent data and family information.
[3] European Patent Office (EPO) Database. Related patent applications and classifications.
[4] USPTO Patent Database. US counterparts and priority data.
[5] Patent landscape analysis reports on pharmaceutical chemical innovations.
This comprehensive review aims to guide industry stakeholders in understanding JP2011157389's patent scope and positioning within the global pharmaceutical patent landscape, underpinning strategic decision-making in drug development and patent management.
